Concomitant antidiabetic therapies were frequently reported, with metformin being the most frequently reported concomitant medication (n = 1,879), followed by pioglitazone (n = 478), insulin glargine (n = 474), glipizide (n = 467), and glimepiride (n = 345) (Figure S1)
148(3): 43945 Cederblad G, Lindstedt S
Being honest about where you fall helps avoid wasting money on a program that does not fit
According to American Thyroid Association guidelines, treatment is typically initiated when TSH rises above 10 mIU/L or when TSH is between 4.5-10 mIU/L with symptoms or positive thyroid antibodies
Adding GIP (the dual-agonist tirzepatide step) meaningfully amplifies the satiety and adipose-tissue effects beyond what GLP-1-only molecules achieve, despite earlier scepticism that GIP signalling was non-functional in type-2 diabetes
Eur Rev